Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Investigation of Uptake in PSMA Expressing Cancer, Biodistribution and Excretion of the Novel Radio Tracer [68Ga]P16-093 by PET/CT

NCT03073395 is registered in ClinicalTrials.gov with Five Eleven Pharma, Inc. as lead sponsor.

NCT NCT03073395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03073395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Investigation of Uptake in PSMA Expressing Cancer, Biodistribution and Excretion of the Novel Radio Tracer [68Ga]P16-093 by PET/CT
Lead sponsor
Five Eleven Pharma, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 21, 2017
Completion date
October 27, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, renal cancer